酵母ベータグルカン市場- 世界の産業規模、シェア、動向、機会、予測、用途別（食品・飲料、パーソナルケア・化粧品、医薬品、飼料、その他）、地域別、競合別、2020年～2030年

酵母ベータグルカンの世界市場規模は、2024年に1億9,232万米ドルとなり、2030年までのCAGRは7.96%で、予測期間には3億520万米ドルに達する見込みです。

予防ヘルスケアと免疫力強化に関する消費者意識の高まりが、酵母ベータグルカン市場成長の主な促進要因です。パン酵母の細胞壁に由来するこの生物活性化合物は、免疫反応を高める能力で知られており、栄養補助食品、機能性食品、健康飲料の添加物として人気があります。パンデミック後のライフスタイルの変化により、天然の免疫増強剤に対する需要が高まっており、メーカー各社は酵母ベータグルカンをウェルネス製品の主流に取り入れるようになっています。

市場拡大のもう一つの主な要因は、医薬品やパーソナルケア用途での酵母ベータグルカンの使用増加です。抗炎症作用、創傷治癒作用、抗酸化作用があるため、スキンケア製剤や治療薬に非常に適しています。消費者がクリーンラベルや科学的裏付けのある成分にシフトする中、化粧品会社や製薬会社は製品の有効性や魅力を高めるために酵母ベータグルカンに投資しており、それによってこの成分の最終用途の可能性が広がっています。

主要市場促進要因

機能性食品と栄養補助食品産業の拡大

主な市場課題

規制の複雑さ

主要市場動向

動物栄養と健康

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の酵母ベータグルカン市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別（食品・飲料、パーソナルケア・化粧品、医薬品、飼料、その他）
  • 地域別
  • 企業別（2024年）
• 製品市場マップ
  • 用途別
  • 地域別

第6章 北米の酵母ベータグルカン市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の酵母ベータグルカン市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン

第8章 アジア太平洋の酵母ベータグルカン市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国

第9章 南米の酵母ベータグルカン市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの酵母ベータグルカン市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Cargill Inc
• Lesaffre Yeast Corp
• EMD Millipore Corp
• Biorigin USA LLC
• Kerry Group PLC
• Lallemand Inc
• Specialty Biotech Co.,LTD.
• VW-Ingredients
• Angel Yeast Co., Ltd.
• Leiber GmbH

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Yeast Beta-glucan Market was valued at USD 192.32 million in 2024 and is expected to reach USD 305.20 million in the forecast period with a CAGR of 7.96% through 2030. The rising consumer awareness around preventive healthcare and immunity enhancement is a key driver for the growth of the yeast beta-glucan market. Derived from the cell walls of baker's yeast, this bioactive compound is known for its ability to boost immune response, making it a popular additive in dietary supplements, functional foods, and health drinks. Post-pandemic lifestyle changes have intensified demand for natural immune boosters, encouraging manufacturers to incorporate yeast beta-glucan into mainstream wellness products.

Another major factor contributing to market expansion is the increasing use of yeast beta-glucan in pharmaceutical and personal care applications. Its anti-inflammatory, wound-healing, and antioxidant properties make it highly suitable for skin care formulations and therapeutic drugs. As consumers shift toward clean-label and scientifically backed ingredients, cosmetic and pharma companies are investing in yeast beta-glucan to enhance the efficacy and appeal of their products, thereby widening the ingredient's end-use potential.

Key Market Drivers

Expanding Functional Foods and Nutraceuticals Industry

The growing focus on preventive health and wellness is significantly boosting the demand for functional foods and nutraceuticals, with yeast beta-glucan gaining prominence as a versatile and evidence-backed ingredient. According to a 2023 survey by FMCG Gurus, 64% of global consumers reported using functional foods to support their immune health. Additionally, nearly 58% of consumers stated they prefer natural bioactives in supplements. Yeast beta-glucan, known for its immune-modulating and cholesterol-lowering benefits, aligns well with these consumer preferences.

Yeast beta-glucan is increasingly incorporated into an array of functional products ranging from granola bars and dairy alternatives to meal-replacement drinks and fortified bakery items. Its neutral taste and excellent solubility allow seamless integration without altering flavor profiles, making it ideal for diverse formulations. Beyond functional foods, nutraceuticals such as capsules and drink powders are being enriched with yeast beta-glucan to target heart health, immunity, and metabolic wellness. As public health concerns continue to rise, this ingredient's wide-ranging applications make it a staple in forward-looking health product development.

As research supporting the efficacy of yeast beta-glucan grows, so does consumer trust in its benefits. Clinical studies have shown that yeast beta-glucan can significantly reduce the duration and severity of upper respiratory tract infections and help modulate the immune response. This scientific validation is crucial in a market where 63% of global consumers say they trust health claims more when supported by research, according to a 2023 Kerry Health and Nutrition Institute report. As a result, brands are leveraging these studies to position their products as science-backed wellness solutions.

In addition to its physiological benefits, yeast beta-glucan offers manufacturers production and labeling advantages. It is gluten-free, vegan, and allergen-friendly-fitting the clean-label trend that dominates consumer choices. With regulatory approvals in major regions including the U.S., EU, and Japan, it enjoys a favorable position for global market expansion. This adaptability allows manufacturers to formulate for various demographics, including aging populations, athletes, and health-conscious millennials, thereby maximizing market penetration and driving sustained demand for yeast beta-glucan across diverse applications.

Key Market Challenges

Regulatory Complexity

Regulatory complexity poses a significant challenge in the global yeast beta-glucan market, particularly as the ingredient is used in diverse applications such as functional foods, dietary supplements, pharmaceuticals, and cosmetics. Different countries and regions have distinct regulatory frameworks governing the approval, labeling, and permissible usage levels of bioactive ingredients like yeast beta-glucan. For instance, while it may be classified as a dietary supplement in one market, it may require novel food approval in another. Navigating these varying standards creates compliance burdens for manufacturers and delays product launches.

Moreover, securing regulatory approvals often involves rigorous clinical documentation and costly testing to validate health claims, especially for immune-boosting or cholesterol-lowering properties. Smaller players in the market may struggle to meet these requirements, hindering innovation and competitiveness. Frequent changes in labeling regulations, safety thresholds, and permissible claims further add to the uncertainty, making global expansion a complex task. As the demand for yeast beta-glucan grows, harmonizing regulations across markets remains critical to unlocking its full commercial potential.

In addition to the fragmented global regulations, manufacturers of yeast beta-glucan face hurdles in gaining recognition for functional claims, particularly in regions with stringent health claim laws such as the European Union. The European Food Safety Authority (EFSA), for instance, requires robust scientific evidence to approve health benefit claims on product labels. While yeast beta-glucan has shown promising results in immunity and cholesterol reduction, the inconsistency in clinical data formats or study populations can lead to delays or rejections in approvals. This not only slows down product development cycles but also adds to the cost and risk of market entry.

Furthermore, regulatory complexity impacts branding and marketing strategies. Companies must tailor product formulations, packaging, and communication for each region to align with local laws. For example, a product marketed as "immune-supporting" in the U.S. may not be allowed to carry the same claim in Asia without country-specific approval. These adjustments reduce economies of scale and complicate supply chains. As consumer awareness grows, inconsistent messaging due to regulatory constraints may also affect consumer trust and brand credibility, making it vital for companies to invest in region-specific regulatory expertise and strategic planning.

Key Market Trends

Animal Nutrition and Health

In a world where the quality and safety of animal-derived products are paramount, the animal nutrition and health industry has been increasingly focusing on natural and sustainable solutions. Yeast beta-glucan, a natural polysaccharide derived from yeast cell walls, has emerged as a key player in promoting the well-being of livestock and aquatic species. One of the fundamental factors driving the demand for yeast beta-glucan in animal nutrition is its ability to enhance the immune system of animals. This natural compound is known for its immunomodulatory properties, which strengthen the immune response in livestock and aquaculture species. As the livestock industry seeks to reduce the use of antibiotics and other synthetic additives, yeast beta-glucan offers a natural alternative to support animal health. A robust digestive system is essential for animal health and productivity. Yeast beta-glucan has been shown to positively impact gut health by promoting beneficial gut microflora and improving nutrient absorption. This is particularly important in poultry and swine production, where efficient digestion plays a crucial role in animal growth and overall health. Stress can have a detrimental effect on animal health and productivity. Yeast beta-glucan has been found to mitigate the negative impacts of stress in animals by modulating the stress response. This is particularly relevant in the aquaculture industry, where stress due to environmental factors can significantly impact fish and shrimp health.

Key Market Players

• Cargill Inc
• Lesaffre Yeast Corp
• EMD Millipore Corp
• Biorigin USA LLC
• Kerry Group PLC
• Lallemand Inc
• Specialty Biotech Co.,LTD.
• VW-Ingredients
• Angel Yeast Co., Ltd.
• Leiber GmbH

Report Scope:

In this report, the Global Yeast Beta-glucan Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Yeast Beta-glucan Market, By Application:

• Food & Beverages
• Personal Care & Cosmetics
• Pharmaceuticals
• Animal Feed
• Others

Yeast Beta-glucan Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Yeast Beta-glucan Market.

Available Customizations:

Global Yeast Beta-glucan market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Yeast Beta-glucan Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Food & Beverages, Personal Care & Cosmetics, Pharmaceuticals, Animal Feed, Others)
  • 5.2.2. By Region
  • 5.2.3. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Application
  • 5.3.2. By Region

6. North America Yeast Beta-glucan Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application (Food & Beverages, Personal Care & Cosmetics, Pharmaceuticals, Animal Feed, Others)
  • 6.2.2. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Yeast Beta-glucan Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
  • 6.3.2. Canada Yeast Beta-glucan Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
  • 6.3.3. Mexico Yeast Beta-glucan Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application

7. Europe Yeast Beta-glucan Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application (Food & Beverages, Personal Care & Cosmetics, Pharmaceuticals, Animal Feed, Others)
  • 7.2.2. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Yeast Beta-glucan Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
  • 7.3.2. United Kingdom Yeast Beta-glucan Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
  • 7.3.3. France Yeast Beta-glucan Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
  • 7.3.4. Italy Yeast Beta-glucan Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
  • 7.3.5. Spain Yeast Beta-glucan Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application

8. Asia-Pacific Yeast Beta-glucan Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application (Food & Beverages, Personal Care & Cosmetics, Pharmaceuticals, Animal Feed, Others)
  • 8.2.2. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Yeast Beta-glucan Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
  • 8.3.2. Japan Yeast Beta-glucan Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
  • 8.3.3. India Yeast Beta-glucan Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
  • 8.3.4. Australia Yeast Beta-glucan Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
  • 8.3.5. South Korea Yeast Beta-glucan Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application

9. South America Yeast Beta-glucan Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application (Food & Beverages, Personal Care & Cosmetics, Pharmaceuticals, Animal Feed, Others)
  • 9.2.2. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Yeast Beta-glucan Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
  • 9.3.2. Argentina Yeast Beta-glucan Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
  • 9.3.3. Colombia Yeast Beta-glucan Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application

10. Middle East and Africa Yeast Beta-glucan Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application (Food & Beverages, Personal Care & Cosmetics, Pharmaceuticals, Animal Feed, Others)
  • 10.2.2. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Yeast Beta-glucan Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
  • 10.3.2. Saudi Arabia Yeast Beta-glucan Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
  • 10.3.3. UAE Yeast Beta-glucan Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
  • 10.3.4. Kuwait Yeast Beta-glucan Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Cargill Inc
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Lesaffre Yeast Corp
• 14.3. EMD Millipore Corp
• 14.4. Biorigin USA LLC
• 14.5. Kerry Group PLC
• 14.6. Lallemand Inc
• 14.7. Specialty Biotech Co.,LTD.
• 14.8. VW-Ingredients
• 14.9. Angel Yeast Co., Ltd.
• 14.10. Leiber GmbH

15. Strategic Recommendations

16. About Us & Disclaimer